Cargando…
Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we eval...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249858/ https://www.ncbi.nlm.nih.gov/pubmed/22229131 http://dx.doi.org/10.4103/2229-5151.84788 |
_version_ | 1782220398638661632 |
---|---|
author | McCluskey, James D Sava, Dmytro Harbison, Stephen C Muro-Cacho, Carlos A Giffe, Johnson T Ping, Xu Harbison, Raymond D |
author_facet | McCluskey, James D Sava, Dmytro Harbison, Stephen C Muro-Cacho, Carlos A Giffe, Johnson T Ping, Xu Harbison, Raymond D |
author_sort | McCluskey, James D |
collection | PubMed |
description | BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we evaluated 3 previously untested water-soluble PARP-1 inhibitors, namely, 3-aminobenzamide (ABA), 5-aminoisoquinolinone (AIQ), and N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide HCl (PJ-34) to determine their efficacy in blocking or attenuating CT-induced hepatotoxicity in male imprinting control region (ICR) mice. STATISTICAL ANALYSIS: Indicators of hepatotoxicity were compared with F-tests among groups to determine statistically significant effects. Pearson's correlation coefficients were used to evaluate the correlation between PARP inhibition and the attenuation of hepatotoxicity. RESULTS AND CONCLUSIONS: CT treatment resulted in hepatic cytotoxicity, increased serum transaminase (ALT), lipid peroxidation (MDA), intracellular glutathione (GSH) depletion, increased carbonyl content, and substantially increased PARP-1 activity. CT treatment also produced profound observable hemorrhagic necrosis in the hepatic centrilobular region of ICR mice. Pretreatment with PJ-34, ABA, and AIQ before CT treatment significantly decreased PARP-1 activity in hepatocytes after CT treatment by 3.4, 2.0, and 1.9 times, respectively. Corresponding to this reduction in PARP-1 activity, a significant reduction in the ALT levels and MDA and a reduction in the GSH depletion were observed. Also, there were no visible tissue defects in the liver samples from animals pretreated with individual PARP-1 inhibitors before CT administration. These results demonstrate the efficacy of the 3 previously untested water-soluble PARP-1 inhibitors in attenuating CT-induced hepatocellular toxicity and further characterize the role of PARP-1 activation and oxidative stress among the cascade of events in hepatocellular necrosis induced by CT treatment. |
format | Online Article Text |
id | pubmed-3249858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32498582012-01-06 Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model McCluskey, James D Sava, Dmytro Harbison, Stephen C Muro-Cacho, Carlos A Giffe, Johnson T Ping, Xu Harbison, Raymond D Int J Crit Illn Inj Sci Original Article BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we evaluated 3 previously untested water-soluble PARP-1 inhibitors, namely, 3-aminobenzamide (ABA), 5-aminoisoquinolinone (AIQ), and N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide HCl (PJ-34) to determine their efficacy in blocking or attenuating CT-induced hepatotoxicity in male imprinting control region (ICR) mice. STATISTICAL ANALYSIS: Indicators of hepatotoxicity were compared with F-tests among groups to determine statistically significant effects. Pearson's correlation coefficients were used to evaluate the correlation between PARP inhibition and the attenuation of hepatotoxicity. RESULTS AND CONCLUSIONS: CT treatment resulted in hepatic cytotoxicity, increased serum transaminase (ALT), lipid peroxidation (MDA), intracellular glutathione (GSH) depletion, increased carbonyl content, and substantially increased PARP-1 activity. CT treatment also produced profound observable hemorrhagic necrosis in the hepatic centrilobular region of ICR mice. Pretreatment with PJ-34, ABA, and AIQ before CT treatment significantly decreased PARP-1 activity in hepatocytes after CT treatment by 3.4, 2.0, and 1.9 times, respectively. Corresponding to this reduction in PARP-1 activity, a significant reduction in the ALT levels and MDA and a reduction in the GSH depletion were observed. Also, there were no visible tissue defects in the liver samples from animals pretreated with individual PARP-1 inhibitors before CT administration. These results demonstrate the efficacy of the 3 previously untested water-soluble PARP-1 inhibitors in attenuating CT-induced hepatocellular toxicity and further characterize the role of PARP-1 activation and oxidative stress among the cascade of events in hepatocellular necrosis induced by CT treatment. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3249858/ /pubmed/22229131 http://dx.doi.org/10.4103/2229-5151.84788 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article McCluskey, James D Sava, Dmytro Harbison, Stephen C Muro-Cacho, Carlos A Giffe, Johnson T Ping, Xu Harbison, Raymond D Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title | Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title_full | Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title_fullStr | Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title_full_unstemmed | Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title_short | Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model |
title_sort | hepatoprotective effects of select water–soluble parp inhibitors in a carbon tetrachloride model |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249858/ https://www.ncbi.nlm.nih.gov/pubmed/22229131 http://dx.doi.org/10.4103/2229-5151.84788 |
work_keys_str_mv | AT mccluskeyjamesd hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT savadmytro hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT harbisonstephenc hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT murocachocarlosa hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT giffejohnsont hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT pingxu hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel AT harbisonraymondd hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel |